WHO ICTRP trial
Investigating the efficacy of early vs. late primaquine treatment for children…
ACTRN12620000855921 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12620000855921 |
|---|---|
| Public title | Investigating the efficacy of early vs. late primaquine treatment for children with uncomplicated malaria due to infection with either Plasmodium vivax or Plasmodium falciparum |
| Scientific title | Investigating the efficacy of early vs. late primaquine treatment for children with uncomplicated malaria due to infection with either Plasmodium vivax or Plasmodium falciparum |
| Primary sponsor | The University of Western Australia |
| Secondary sponsors | Curtin University;Papua New Guinea Institute of Medical Research |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | Papua New Guinea |
| Conditions | Malaria; Malaria;Infection - Other infectious diseases |
| Interventions | Using computer generated randomisation, children will be allocated 1:1 to either treatment Arm 1 or 2 of the study. Arm 1 (comparator arm): Artemether-lumefantrine: Oral administration as 1.7 mg/kg artemether and 10 mg/kg lumefantrine given… |
| Registration date | Aug 27, 2020 |
| Target size | 220 |
| Secondary IDs | NHMRC1130301 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: